Newcelx Ltd (NCEL)

$2.74 -0.05 (-1.79%)
Market Cap 12.49M
Revenue (ttm) 0.00
Net Income (ttm) -1.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 11,300
Avg Vol 105,256
Day's Range N/A - N/A
Shares Out 4.56M
Stochastic %K 37%
Beta 0.15
Analysts Strong Buy
Price Target N/A

Company Profile

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

Industry: Biotechnology
Sector: Healthcare
Phone: 41 44 512 21 50
Fax: 41 44 512 21 51
Website: newcelx.com
Address:
The Circle 6, Zurich, Switzerland
Veraton
Veraton Mar. 10 at 2:54 PM
$ELDN $NCEL 💯%
0 · Reply
bulldawgdoc
bulldawgdoc Mar. 10 at 2:53 PM
$ELDN maybe Eledon got tired of waiting around for vertex’s insulin producing stem cells and found themselves another company to collab with. I might buy some $NCEL float is only 5m shares and looks like it has been beaten down this year. Might be a buy and hold and see what the collab with Eledon does.
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 9 at 12:06 PM
$NCEL 5m low float Newcelx announced a collaboration with Eldon Pharmaceuticals to advance NCEL-101 for Type 1 Diabetes. The partnership combines Newcelx’s stem-cell-derived islet therapy with Eldon’s anti-CD40L antibody tegoprubart, designed to prevent immune rejection of transplanted cells. Tegoprubart already has clinical experience in 100+ transplant patients, adding credibility to the approach. Goal: improve durability and survival of transplanted islet cells, potentially moving closer to a functional cure for Type 1 diabetes. Bull case: this strengthens NCEL-101’s development strategy, adds transplant expertise, and could accelerate regulatory clarity and clinical progress.
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 9 at 12:00 PM
$NCEL
0 · Reply
Mister_Bungle
Mister_Bungle Feb. 27 at 11:40 PM
$NCEL the volume on this stock is absolutely embarrassing 😭😭. We need a miracle
0 · Reply
Jj1369
Jj1369 Feb. 20 at 9:27 PM
$NCEL shorting this back under $1.00 Alex Zwyer is a fraud should of stayed in the caviar business
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 2:01 AM
$NCEL Current Stock Price: $2.74
0 · Reply
vixmax
vixmax Feb. 17 at 8:08 AM
$NCEL Pre-revenue biotech; early-stage oncology
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 16 at 10:51 PM
$NCEL RSI: 55.48, MACD: 0.0030 Vol: 0.16, MA20: 2.68, MA50: 2.73 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Diverter
Diverter Feb. 12 at 5:54 PM
$NCEL Sometimes I seriously wonder: why do some companies announce record profits or win massive contracts, yet their stock price barely moves? Good news passes by like it’s nothing, as if the stock is in a coma. Is it because big institutions are buying slowly on purpose, or have passive funds (ETFs) taken over pricing regardless of company performance? Has the market simply stopped rewarding good companies? Just an open question—curious if anyone has insights.
1 · Reply
Latest News on NCEL
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Mar 9, 2026, 7:00 AM EDT - 6 days ago

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

ELDN

NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

Feb 12, 2026, 7:00 AM EST - 4 weeks ago

NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

Jan 29, 2026, 7:00 AM EST - 6 weeks ago

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression

Jan 12, 2026, 7:00 AM EST - 2 months ago

NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression

NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board

Jan 5, 2026, 7:00 AM EST - 2 months ago

NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

Dec 11, 2025, 7:00 AM EST - 3 months ago

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

Nov 17, 2025, 7:00 AM EST - 4 months ago

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

Nov 6, 2025, 7:00 AM EST - 4 months ago

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

NewcelX CEO Issues Letter to Shareholders

Nov 4, 2025, 7:00 AM EST - 4 months ago

NewcelX CEO Issues Letter to Shareholders

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Nov 3, 2025, 8:25 AM EST - 4 months ago

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

NLSP

Veraton
Veraton Mar. 10 at 2:54 PM
$ELDN $NCEL 💯%
0 · Reply
bulldawgdoc
bulldawgdoc Mar. 10 at 2:53 PM
$ELDN maybe Eledon got tired of waiting around for vertex’s insulin producing stem cells and found themselves another company to collab with. I might buy some $NCEL float is only 5m shares and looks like it has been beaten down this year. Might be a buy and hold and see what the collab with Eledon does.
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 9 at 12:06 PM
$NCEL 5m low float Newcelx announced a collaboration with Eldon Pharmaceuticals to advance NCEL-101 for Type 1 Diabetes. The partnership combines Newcelx’s stem-cell-derived islet therapy with Eldon’s anti-CD40L antibody tegoprubart, designed to prevent immune rejection of transplanted cells. Tegoprubart already has clinical experience in 100+ transplant patients, adding credibility to the approach. Goal: improve durability and survival of transplanted islet cells, potentially moving closer to a functional cure for Type 1 diabetes. Bull case: this strengthens NCEL-101’s development strategy, adds transplant expertise, and could accelerate regulatory clarity and clinical progress.
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 9 at 12:00 PM
$NCEL
0 · Reply
Mister_Bungle
Mister_Bungle Feb. 27 at 11:40 PM
$NCEL the volume on this stock is absolutely embarrassing 😭😭. We need a miracle
0 · Reply
Jj1369
Jj1369 Feb. 20 at 9:27 PM
$NCEL shorting this back under $1.00 Alex Zwyer is a fraud should of stayed in the caviar business
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 2:01 AM
$NCEL Current Stock Price: $2.74
0 · Reply
vixmax
vixmax Feb. 17 at 8:08 AM
$NCEL Pre-revenue biotech; early-stage oncology
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 16 at 10:51 PM
$NCEL RSI: 55.48, MACD: 0.0030 Vol: 0.16, MA20: 2.68, MA50: 2.73 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Diverter
Diverter Feb. 12 at 5:54 PM
$NCEL Sometimes I seriously wonder: why do some companies announce record profits or win massive contracts, yet their stock price barely moves? Good news passes by like it’s nothing, as if the stock is in a coma. Is it because big institutions are buying slowly on purpose, or have passive funds (ETFs) taken over pricing regardless of company performance? Has the market simply stopped rewarding good companies? Just an open question—curious if anyone has insights.
1 · Reply
TheTradeXchange
TheTradeXchange Feb. 12 at 12:01 PM
$NCEL NCEL NCEL - NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy
0 · Reply
Mister_Bungle
Mister_Bungle Feb. 10 at 3:03 AM
$NCEL if you are thinking of adding this, don't do it. Most of us are stuck because of the crazy manipulation when the merger happened. Now we're all praying it gets to 4 or 5 dollars
0 · Reply
sweepjosh
sweepjosh Feb. 9 at 11:05 AM
$NCEL is a cell therapy biotech; it faces the universal challenges of the field: manufacturing complexity, durability of response, and the high cost of goods, which must be solved for commercial viability.
0 · Reply
can8232
can8232 Feb. 6 at 9:11 AM
$NCEL Dear friends, I have a refinery mandate to sell crude oil, diesel or aircraft and all types of oil, in large quantities, the goods are directly from my refinery in Kazakhstan or Azerbaijan, Anyone interested in buying, I would be happy to contact me by email: [email protected]
0 · Reply
Evilmarine
Evilmarine Jan. 29 at 6:45 PM
$NCEL added some 😆
0 · Reply
crabhunter
crabhunter Jan. 29 at 1:42 PM
$NCEL Patience
0 · Reply
Jdorkshire
Jdorkshire Jan. 27 at 5:43 PM
$NCEL I feel your pain however look at a 90d 1hr chart before you make a decision
0 · Reply
Mister_Bungle
Mister_Bungle Jan. 27 at 5:12 PM
$NCEL been screwed so heavily by these bastards. Can't decide if I should finally sell or just keep holding my 15k shares. I'm afraid it's gonna dump later today or tomorrow
1 · Reply
Jdorkshire
Jdorkshire Jan. 27 at 4:07 PM
$NCEL Ok now awaiting volume push
0 · Reply
crabhunter
crabhunter Jan. 26 at 12:55 PM
$NCEL Patience…
0 · Reply
crabhunter
crabhunter Jan. 23 at 3:46 PM
$NCEL very reluctant/lagging bid. baiting traders to sell lower...
0 · Reply
crabhunter
crabhunter Jan. 23 at 3:43 PM
$NCEL just saw 97K flashed on teh bid....
0 · Reply